Amgen (AMGN) Tops Q2 EPS by 38c, Offers FY Guidance
Get Alerts AMGN Hot Sheet
Price: $401.32 -0.43%
Revenue Growth %: +5.1%
Financial Fact:
Other revenues: 295M
Today's EPS Names:
VFS, PKE, More
Revenue Growth %: +5.1%
Financial Fact:
Other revenues: 295M
Today's EPS Names:
VFS, PKE, More
Join SI Premium – FREE
Amgen (NASDAQ: AMGN) reported Q2 EPS of $3.97, $0.38 better than the analyst estimate of $3.59. Revenue for the quarter came in at $5.9 billion versus the consensus estimate of $5.68 billion.
GUIDANCE:
Amgen sees FY2019 EPS of $13.75-$14.30, versus the consensus of $13.97. Amgen sees FY2019 revenue of $22.4-22.9 billion, versus the consensus of $22.59 billion.
For earnings history and earnings-related data on Amgen (AMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alethia Capital Starts TTM Technologies (TTMI) at Overweight, 'A Unique Proxy Standing for USA PCB'
- S&P Global (SPGI) PT Lowered to $531 at Mizuho
- Raymond James Reiterates Outperform Rating on Camping World Holdings (CWH)
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share